12 April 2017 1 Min Read
Blue Label restructuring involving Cell C and Net1 ‘on track’
The deal could be delayed at the competition authorities as public interest issues are extensively interrogated
Subscribe to our website to read this article and support quality journalism.
If you’ve already subscribed, simply sign in.
Subscribe Sign In